Rwanda on Sunday started an Ebola vaccinationn activitynat its border with the Democratic Republic of Congo.
The country is using a vaccine developed by US group Johnson & Johnson, the country’s health minister, Diane Gashumba said.
The vaccine, Ad26-ZEBOV-GP, is an experimental drug produced by US pharmaceuticals giant, Johnson & Johnson.
The vaccine was used the first time mid-November in Goma in DR Congo, on the other side of the border.
So far, there have no confirmed cases of Ebola in Rwanda.
More than 250,000 people in DR Congo have already been vaccinated using another product, rVSV-ZEBOV that was made by US drug company, Merck Shape and Dohme.
The first volunteers expressed relief at the measure.
The head of DR Congo’s anti-Ebola efforts, Jean-Jacques Muyembe, and the WHO’s representative in Rwanda, Kasonde Mwinga, were present at the campaign launch.